Cytokinetics Inc (CYTK)’s stock is trading at $62.56 at the moment marking a fall of -1.21% from the last session close. As of this writing, shares are priced at -11.86% less than their 52-week high of $70.98, and 113.45% over their 52-week low of $29.31.
How does Cytokinetics Inc (CYTK) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Cytokinetics Inc (CYTK): Earnings History
If we examine Cytokinetics Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$1.54, slashing the consensus of -$1.57. In other words, it beat the consensus by $0.02, resulting in a 1.57% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$1.54 in contrast with the Outlook of -$1.57. That was a difference of $0.02 and a surprise of 1.57%.
Cytokinetics Inc (NASDAQ: CYTK) Ownership Details
I will give a breakdown of the key shareholders in Cytokinetics Inc (CYTK). Recent figures show that the company’s insiders hold 0.74% of shares. A total of 521 institutional investors hold shares in the company, making 118.42% of its stock and 119.30% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is T. Rowe Price Investment Management, Inc. holding total of 19.08 shares that make 15.61% of the company’s total number of shares and are currently priced at 1.19 billion.
The securities firm Blackrock Inc. holds 15.53 shares of CYTK, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 12.70%, and the holding percentage of shares is valued at 970.2 million.
